← back to search

Juha Mehtonen

University of Helsinki · FI
🔎 Find collaborators in Molecular Biology · Public Health, Environmental and Occupational Health →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Molecular Biology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Acute Lymphoblastic Leukemia research, Bioinformatics and Genomic Networks, Acute Myeloid Leukemia Research, and Cancer Genomics and Diagnostics.
h-index
24
citations
2,865
works
99
NIH funding
primary concept
Biology
email

Recent publications

H1‐0 is a specific mediator of the repressive ETV6::RUNX1 transcriptional landscape in preleukemia and B cell acute lymphoblastic leukemia
HemaSphere 2025cited by 4position: middledoi
Sequential drug treatment targeting cell cycle and cell fate regulatory programs blocks non-genetic cancer evolution in acute lymphoblastic leukemia
Genome biology 2024cited by 12position: middledoi
A second update on mapping the human genetic architecture of COVID-19
Nature 2023cited by 111position: middledoi
Genetic predictors of lifelong medication-use patterns in cardiometabolic diseases
Nature Medicine 2023cited by 35position: middledoi
Overlap of Genetic Loci for Central Serous Chorioretinopathy With Age-Related Macular Degeneration
JAMA Ophthalmology 2023cited by 21position: middledoi
Recurrent Germline Variant in RAD21 Predisposes Children to Lymphoblastic Leukemia or Lymphoma
International Journal of Molecular Sciences 2022cited by 7position: middledoi
Mapping the human genetic architecture of COVID-19
Nature 2021cited by 1,112position: middledoi
Germline POT1 Deregulation Can Predispose to Myeloid Malignancies in Childhood
International Journal of Molecular Sciences 2021cited by 11position: middledoi
Recurrent Germline Variant in the Cohesin Complex Gene <i>RAD21</i> Predisposes Children to Lymphoblastic Leukemia and Lymphoma
Blood 2021cited by 0position: middledoi
Single cell characterization of B-lymphoid differentiation and leukemic cell states during chemotherapy in ETV6-RUNX1-positive pediatric leukemia identifies drug-targetable transcription factor activities
Genome Medicine 2020cited by 56position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Carolin Walter · University of Münster2 papers (2021–2021)Olli Lohi · Technical University of Munich2 papers (2020–2024)Martin Dugas · Heidelberg University2 papers (2021–2021) · 2 papers (2021–2021)Alena Malyukova · Karolinska Institutet2 papers (2020–2024)Olle Sangfelt · Karolinska Institutet2 papers (2020–2024)Franziska Auer · New York University2 papers (2021–2021)Arndt Borkhardt · Düsseldorf University Hospital2 papers (2021–2021)Ulrike Friedrich · German Cancer Research Center2 papers (2021–2021)Julia Hauer · München Klinik Schwabing2 papers (2021–2021) · 2 papers (2020–2024) · 2 papers (2020–2024)Triantafyllia Brozou · Heinrich Heine University Düsseldorf2 papers (2021–2021)Rabea Wagener · Universität Ulm2 papers (2021–2021) · 2 papers (2021–2021) · 1 papers (2020–2020)Daniela Richter · National Center for Tumor Diseases1 papers (2021–2021)Karen Akopyan · Karolinska Institutet1 papers (2024–2024)Stefan Fröhling · German Cancer Research Center1 papers (2021–2021)Miriam Erlacher · University of Freiburg1 papers (2021–2021)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Molecular Biology · Public Health, Environmental and Occupational Health →